Finance

Beta
Lists
AGMB:NASDAQ
Agomab Therapeutics NV
$13.03
+2.28%
(+0.29) 1D
Jul 9, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AGMB...
Open
$13.10
High
$13.30
Low
$12.74
Mkt. cap
668.90M
Avg. vol.
113.35K
Volume
0.00
52-wk high
$17.82
52-wk low
$8.75
EPS
-$1.46
No. of employees
62
Open
$13.10
High
$13.30
Low
$12.74
Mkt. cap
668.90M
Avg. vol.
113.35K
Volume
0.00
52-wk high
$17.82
52-wk low
$8.75
EPS
-$1.46
No. of employees
62
News stories
From sources across the web
About Agomab Therapeutics NV
CEO-
Employees62
Founded2017
Headquarters-
SectorPharmaceutical industry
Websiteagomab.com
Analyst ratings
Based on 2 analysts giving stock ratings to AGMB in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for AGMB in the last 3 months.
Highest
Current $13.03
$35.00 (+168.61%)
Average
$22.78 (+74.83%)
Lowest
$10.55 (-19.03%)
Analyst
Recommendation
Action
Price target
Projected
Date
Patrick Trucchio
H.C. Wainwright
Buy
Initiated
$35.00
+168.6%
06/22/2026
Judah Frommer
Morgan Stanley
Buy
Maintained
$10.55
-19%
05/18/2026
Anupam Rama
J.P. Morgan
Buy
Initiated
$32.00
+145.6%
03/03/2026
Thomas Smith
Leerink Partners
Buy
Initiated
$36.00
+176.3%
03/03/2026
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Dec 2024
Dec 2025
Revenue
-
-
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
10.73M
13.86M
Total research and development expenses
-
-
Selling, general, and admin expenses
1.47M
3.17M
Operating expense
11.81M
16.53M
Total operating expenses
11.81M
16.53M
Operating income
-11.81M
-16.53M
Other non operating income
-309.00K
-1.54M
EBT including unusual items
-11.73M
-17.40M
EBT excluding unusual items
-11.73M
-17.40M
Income tax expense
4.00K
-
Effective tax rate
-0.03%
-
Other operating expenses
-383.00K
-506.00K
Net income
-11.73M
-17.40M
Net profit margin
-
-
Earnings per share
-
-
Interest and investment income
626.00K
720.00K
Interest expense
-
-
Net interest expenses
626.00K
720.00K
Depreciation and amortization charges
-
-
EBITDA
-11.80M
-16.51M
Gain or loss from assets sale
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer